Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FARICIMAB for Retinal vein occlusion: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where FARICIMAB was used for Retinal vein occlusion.

Most Reported Side Effects for FARICIMAB

Side Effect Reports % Deaths Hosp.
Off label use 32 8.4% 0 3
Uveitis 31 8.1% 0 0
No adverse event 27 7.1% 0 0
Drug ineffective 22 5.8% 0 1
Eye inflammation 18 4.7% 0 0
Cataract 16 4.2% 0 4
Death 16 4.2% 16 0
Vitritis 16 4.2% 0 0
Retinal haemorrhage 15 3.9% 0 3
Blindness 14 3.7% 0 0
Neovascular age-related macular degeneration 14 3.7% 0 1
Diabetic retinopathy 13 3.4% 0 1
Visual acuity reduced 13 3.4% 0 0
Iridocyclitis 12 3.2% 0 2
Cerebrovascular accident 10 2.6% 0 6

Other Indications for FARICIMAB

Neovascular age-related macular degeneration (131) Diabetic retinal oedema (123) Product used for unknown indication (61) Macular oedema (20) Age-related macular degeneration (16) Choroidal neovascularisation (8) Central serous chorioretinopathy (5)

Other Drugs Used for Retinal vein occlusion

AFLIBERCEPT (1,928) RANIBIZUMAB (1,354) BEVACIZUMAB (379) DEXAMETHASONE (280) FARICIMAB\FARICIMAB-SVOA (189) FARICIMAB-SVOA (104) LUCENTIS (51) TRIAMCINOLONE ACETONIDE (44) FLUOCINOLONE ACETONIDE (30) TRIAMCINOLONE (30)

Related Pages

FARICIMAB Full Profile All Retinal vein occlusion Drugs FARICIMAB Demographics FARICIMAB Timeline